v3.26.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Stockholders' Equity
Note 7 – Stockholders' Equity
Stock Option and SAR Activity
A summary of stock option and SAR activity for the six months ended June 30, 2026 is as follows (in millions, except share amounts which are reflected in thousands, per share amounts, and years):
SARs Outstanding Number of SARsOptions Outstanding Number of SharesWeighted-Average Exercise Price Per ShareWeighted-Average Remaining Contractual Life (in years)Aggregate Intrinsic Value
As of December 31, 202516 5,868 $48.72 4.79$194 
Granted— 619 $75.51 
Exercised(6)(169)$34.44 
Canceled and forfeited— (219)$59.95 
As of June 30, 202610 6,099 $51.44 4.56$132 
Exercisable as of June 30, 202610 3,557 $41.17 3.78$112 
RSU Activity
The following table summarizes the activity related to our RSUs for the six months ended June 30, 2026 (in thousands, except per share amounts):
Number of SharesWeighted-Average
 Grant-Date Fair
 Value per Share
Unvested and outstanding as of December 31, 202557,654 $65.69 
Granted35,921 $73.57 
Vested(17,008)$56.31 
Canceled and forfeited(4,763)$68.59 
Unvested and outstanding as of June 30, 202671,804 $71.66 
Stock-Based Compensation Expense
Stock-based compensation expense is allocated based on the cost center to which the award holder belongs. The following table summarizes total stock-based compensation expense by function (in millions):
Three Months Ended June 30,Six Months Ended June 30,
2025202620252026
Operations and support$59 $71 $111 $131 
Sales and marketing28 27 52 52 
Research and development284 336 548 622 
General and administrative104 122 199 224 
Total$475 $556 $910 $1,029 
As of June 30, 2026, there was $4.9 billion of unamortized compensation costs related to all unvested awards. The unamortized compensation costs are expected to be recognized over a weighted-average period of approximately 2.93 years.
The income tax benefits recognized in the condensed consolidated statements of operations for stock-based compensation expense were not material during the three and six months ended June 30, 2025 and 2026.
Share Repurchase Program
In July 2025, our board of directors authorized an additional $20.0 billion for the repurchase of common stock (“Share Repurchase Program”). The timing, manner, price and amount of any repurchases are determined by the discretion of management, depending on market conditions and other factors. Repurchases may be made through open market purchases and accelerated share repurchases. The exact number of shares to be repurchased by us, if any, is not guaranteed. Depending on market conditions and other factors, these repurchases may be commenced or suspended at any time or periodically without prior notice.
During the three and six months ended June 30, 2025, we repurchased, and subsequently retired, 16.4 million and 42.9 million shares of common stock for $1.4 billion and $3.2 billion, respectively, excluding broker commissions and fees.
During the three and six months ended June 30, 2026, we repurchased, and subsequently retired, 6.9 million and 46.6 million shares of common stock for $510 million and $3.5 billion, respectively, excluding broker commissions and fees. As of June 30, 2026, we had approximately $15.7 billion available to repurchase shares pursuant to the Share Repurchase Program.
The Inflation Reduction Act imposed a nondeductible 1% excise tax on the net value of certain stock repurchases. During the three and six months ended June 30, 2025 and 2026, the excise tax on net share repurchases was not material.